NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · Real-Time Price · USD
2.400
-0.050 (-2.04%)
At close: Nov 20, 2024, 4:00 PM
2.250
-0.150 (-6.25%)
After-hours: Nov 20, 2024, 7:51 PM EST
NeuroBo Pharmaceuticals Market Cap
NeuroBo Pharmaceuticals has a market cap or net worth of $20.68 million as of November 21, 2024. Its market cap has increased by 18.84% in one year.
Market Cap
20.68M
Enterprise Value
-848.58K
1-Year Change
18.84%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since August 5, 2016, NeuroBo Pharmaceuticals's market cap has decreased from $84.50M to $20.68M, a decrease of -75.53%. That is a compound annual growth rate of -15.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 20.70M | 15.64% |
| Dec 29, 2023 | 17.90M | 280.85% |
| Dec 30, 2022 | 4.70M | -85.49% |
| Dec 31, 2021 | 32.40M | -62.41% |
| Dec 31, 2020 | 86.20M | 1,557.69% |
| Dec 31, 2019 | 5.20M | -55.17% |
| Dec 31, 2018 | 11.60M | -86.27% |
| Dec 29, 2017 | 84.50M | 16.23% |
| Dec 30, 2016 | 72.70M | -13.96% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlycoMimetics | 21.28M |
| Pieris Pharmaceuticals | 21.20M |
| Cocrystal Pharma | 20.96M |
| MIRA Pharmaceuticals | 20.95M |
| Enlivex Therapeutics | 20.89M |
| Pulmatrix | 20.53M |
| BriaCell Therapeutics | 20.52M |
| Exicure | 20.51M |